Back
Adaptimmune Therapeutics PLC Quote, Financials, Valuation and Earnings
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
23
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.04
Seasonality Move:
-31.44%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmAdaptimmune Therapeutics PLC Price Quote
$1.04
Adaptimmune Therapeutics PLC Key Stats
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Day range:
$1.02 - $1.07
52-week range:
$0.42 - $2.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.76
P/B ratio:
2.76%
Volume:
955.1K
Avg. volume:
1.4M
1-year change:
40.45%
Market cap:
$266M
Revenue:
$60.3M
EPS:
$-0.3
How Much Does Adaptimmune Therapeutics PLC Make?
-
How Much Are Adaptimmune Therapeutics PLC's Sales Annually?
ADAP Revenues are $60.3M -
How Much Profit Does Adaptimmune Therapeutics PLC's Make A Year?
ADAP net income is -$113.9M
Is Adaptimmune Therapeutics PLC Growing As A Company?
-
What Is Adaptimmune Therapeutics PLC's Growth Rate Quarterly?
Quarterly YoY revenue growth is 24% -
What Is Adaptimmune Therapeutics PLC's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Adaptimmune Therapeutics PLC Stock Price Performance
-
Did Adaptimmune Therapeutics PLC Stock Go Up Last Month?
Adaptimmune Therapeutics PLC share price went down by -3.7% last month -
Did ADAP's Share Price Rise Over The Last Year?
ADAP share price rose by 40.45% over the past 1 year
What Is Adaptimmune Therapeutics PLC 52-Week High & Low?
-
What Is Adaptimmune Therapeutics PLC’s 52-Week High Share Price?
Adaptimmune Therapeutics PLC has traded as high as $2.05 over the past 52 weeks -
What Is Adaptimmune Therapeutics PLC’s 52-Week Low Share Price?
Adaptimmune Therapeutics PLC has traded as low as $0.42 over the past 52 weeks
Adaptimmune Therapeutics PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Adaptimmune Therapeutics PLC?
-
How Much Debt Does Adaptimmune Therapeutics PLC Have?
Total long term debt quarterly is $25M -
How Much Cash Does Adaptimmune Therapeutics PLC Have?
Cash and short term investments quarterly total is $214.8M -
What Is Adaptimmune Therapeutics PLC’s Book Value Per Share?
Book value per share is 0.38
Is Adaptimmune Therapeutics PLC Cash Flow Positive?
-
What Is ADAP Cash Flow From Operations?
Cash flow from operations (TTM) is -$44.4M -
What Is Adaptimmune Therapeutics PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $54.4M -
What Is Adaptimmune Therapeutics PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is $124.4M
Adaptimmune Therapeutics PLC Return On Invested Capital
-
Is Management Doing A Good Job?
ADAP return on invested capital is -90.65% -
What Is Adaptimmune Therapeutics PLC Return On Assets?
ROA measures how assets are converting to revenues and is -24.14% -
What Is ADAP Return On Equity?
ROE is a measure of profitability and is -96.68%
Adaptimmune Therapeutics PLC Earnings Date & Stock Price
-
What Is Adaptimmune Therapeutics PLC's Stock Price Today?
A single share of ADAP can be purchased today for 1.04 -
What Is Adaptimmune Therapeutics PLC’s Stock Symbol?
Adaptimmune Therapeutics PLC trades on the nasdaq under the ticker symbol: ADAP -
When Is Adaptimmune Therapeutics PLC’s Next Earnings Date?
The next quarterly earnings date for Adaptimmune Therapeutics PLC is scheduled on November 8, 2024 -
When Is ADAP's next ex-dividend date?
Adaptimmune Therapeutics PLC's next ex-dividend date is September 19, 2024 -
How To Buy Adaptimmune Therapeutics PLC Stock?
You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Adaptimmune Therapeutics PLC Competitors
-
Who Are Adaptimmune Therapeutics PLC's Competitors?
Below is a list of companies who compete with Adaptimmune Therapeutics PLC or are related in some way:
Adaptimmune Therapeutics PLC Dividend Yield
-
What Is ADAP Dividend Yield?
Adaptimmune Therapeutics PLC’s dividend yield currently is 0% -
What Is Adaptimmune Therapeutics PLC’s Payout Ratio?
Adaptimmune Therapeutics PLC’s payout ratio is 0% -
When Did Adaptimmune Therapeutics PLC Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Adaptimmune Therapeutics PLC’s Dividend Per Share?
Adaptimmune Therapeutics PLC pays a dividend of $0.00 per share
Adaptimmune Therapeutics PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 220.6% |
| Revenue: | 2399.63% | 186.47% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 2.74 |
| Upside from Last Price: | 163.35% |